Achievement of complete donor-type chimerism and remission with dasatinib in Philadelphia chromosome-positive ALL relapsing after allogeneic transplantation.
Conchon
M
M
Sanabani
S S
SS
Bendit
I
I
Serpa
M
M
Filho
U A
UA
de Barros Ferreira
P
P
Novaes
M M Y
MM
Saboya
R
R
Llacer-Dorliac
P E
PE
Dulley
F L
FL
D000328:Adult; D000069439:Dasatinib; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D008297:Male; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000628:therapy*; D011743:Pyrimidines / Q000627:therapeutic use*; D012074:Remission Induction; D016879:Salvage Therapy / Q000379:methods; D013844:Thiazoles / Q000627:therapeutic use*; D018183:Transplantation Chimera; D014184:Transplantation, Homologous
D011743:Pyrimidines; D013844:Thiazoles; D000069439:Dasatinib